Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.09 - Mesothelioma
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Mesothelioma
-
+
P1.09-001 - Multiplexed Biomarker Strategies Based on Targeted Proteomics for Detection of Malignant Pleural Mesothelioma in Blood
09:30 - 09:30 | Presenter: Ferdinando Cerciello | Author(s): M. Choi, K. Lome, J.M. Amann, E. Felley-Bosco, Rolf A Stahel, B. Robinson, J. Creaney, Harvey I Pass, O. Vitek, David P Carbone
- Abstract
Loading...
-
+
P2.02 - Biology/Pathology
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Biology/Pathology
-
+
P2.02-065 - RanBP9 is a Novel Prognostic and Predictive Biomarker for NSCLC and Affects Cellular Response to Cisplatin and PARP Inhibitors
09:30 - 09:30 | Presenter: Anna Tessari | Author(s): D. Palmieri, M. Pawlikowski, K. Parbhoo, C. Foray, M. Fassan, K. La Perle, E. Rulli, A. Fabbri, M. Ganzinelli, V. Embrione, M. Broggini, J.M. Amann, David P Carbone, Marina Chiara Garassino, C.M. Croce, V. Coppola
- Abstract
Loading... -
+
P2.02-067 - LKB1 Loss Is Associated with DNA Hypomethylation in Human Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Michael John Koenig | Author(s): J.M. Amann, C. Oakes, J.M. Kaufman, David P Carbone
- Abstract
Loading...
-
+
P3.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P3.03-002 - Histone Deacetylase Inhibition Enhances the Antitumor Activity of a MEK Inhibitor in Lung Cancer Cells Harboring RAS Mutations
09:30 - 09:30 | Presenter: Tadaaki Yamada | Author(s): J.M. Amann, A. Tanimoto, Hirokazu Taniguchi, T. Shukuya, S. Yano, K. Takayama, David P Carbone
- Abstract
Loading...